You are here

Vaccines

Primary tabs

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Members

Kathy Gilbeaux mdmcdonald MDMcDonald_me_com mike kraft

Email address for group

vaccines_global@m.resiliencesystem.org

UK's recommendations for fall COVID boosters

...

In its announcement today, the UK's Joint Committee on Vaccination and Immunization (JCVI) detailed the people who will be eligible to receive the vaccine in the fall—those most likely to benefit from vaccination. Aside from those ages 65 and older, the list includes people in nursing facilities and their caregivers, people ages 6 months to 64 who are in clinical risk groups, people ages 12 to 64 who are family contacts of immunocompromised people, and frontline health and social care workers.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Negative view of COVID vaccines continue - new polls

...

The results of the present study show many Americans still hold a dismissive view of COVID-19 vaccines. As of April 2023, 30% of the population have not been vaccinated with primary doses, and 83% of those eligible have not received a booster dose.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Bivalent COVID-19 booster outperforms monovalent version --new study

A new Italian study finds that estimated relative vaccine effectiveness (rVE) was 49.3% for the bivalent (two-strain) booster and 26.9% for the monovalent (single-strain) booster, with protection lasting at least 4 months for the bivalent booster and waning fast for the monovalent version. The study appears in The Lancet Infectious Diseases.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 0.764 seconds.